Clinical Trial Update: Losartan to Improve Hip Microfracture [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating losartan for hip cartilage repair in osteoarthritis and impingement conditions was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cartilage Damage
• Fibrosis
• Hip Impingement Syndrome
• Hip Osteoarthritis

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Steadman Philippon Research Institute | Conditions: Hip Osteoarthritis, Hip Impingement Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-10-30